Oblique Therapeutics' Unattributed Round

Oblique Therapeutics raised a round of funding on December 14, 2015. Investors include ALMI.

Oblique Therapeutics is developing new types of antibody-based drugs used for the defense against malignant tumors.…

Articles about Oblique Therapeutics' Unattributed Round: